Inflammatory Arthritis
67
10
21
20
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.5%
5 terminated out of 67 trials
80.0%
-6.5% vs benchmark
7%
5 trials in Phase 3/4
35%
7 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (67)
Assessing Central Aspects of Pain
Palliative and Supportive Care to Help People With Arthritis to Live Well (ENRICH)
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
DEXA Bone Density Analysis of the CoreHip® Prosthesis System
Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Effect of a Self-Management Intervention for Patients Newly Diagnosed With Inflammatory Arthritis: The NISMA Trial
Allofit® IT With HXPE in Total Hip Arthroplasty
Rotator Cuff Sparing Total Arthroplasty
Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations and Immune Infiltrate Characterization : the UTOPIC Project
3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)
COMFI - a COMbined Fatigue Intervention
Personalized Outreach for Equitable Treatment in Rheumatology
Differentiate Children Septic and Inflammatory Arthritis by Comparative Analysis
Exception Cementless Hip Stem
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study